Clinical trial of Modified Shenling Baizhu Powder in the treatment of spleen deficiency and dampness turbidity syndrome of chronic nephritis

Phase 1

• Conditions: chronic nephritis

• Registration Number: ITMCTR2200006570
• Lead Sponsor: Xiyuan Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

a) Diagnosed as chronic nephritis;
b) TCM syndrome differentiation belongs to spleen and kidney qi deficiency and dampness turbidity syndrome;
c) Age 18 ~ 65 years old;
d) The 24-hour urinary protein content is 0.5g ~ 3g;
e) eGFR>60 ml/(min·1.73m2)

Exclusion Criteria

a) Except purpura nephritis, lupus nephritis and other secondary glomerular diseases;
b) Pregnant and lactating women;
c) Complicated with serious mental disorders or serious cardiovascular, cerebrovascular and liver diseases.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rine protein quantitation for 24 hours;

Secondary Outcome Measures

Name	Time	Method
Albumin;Blood creatinine;Triglyceride;Glomerular filtration rate;Uric acid;Repeated or aggravated times of hematuria and proteinuria;Cholesterol;TCM symptom score;Urea nitrogen;Urine red blood cell count;